Claudio Pisano

7.2k citations

169 papers · 6.0k indexed · h-index 48

Impact in

Toxicology top 0.5%
Cell Biology top 0.5%
- Proteoglycans and glycosaminoglycans research

Papers in

Toxicology 12
- Bioactive Compounds and Antitumor Agents 12
Oncology 55
- Peptidase Inhibition and Analysis 14
- Lung Cancer Research Studies 11

Co-authors: Franco Zunino Loredana Vesci Paolo Carminati Giuseppe Giannini Israël Vlodavsky Sergio Penco Sabrina Dallavalle Silvia Bonaccorsi
Journals: Journal of Medicinal Chemistry (18 papers)Biochemical Pharmacology (9 papers)Cancer Research (8 papers)Bioorganic & Medicinal Chemistry (7 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)
Partner nations: Italy Switzerland Lebanon

In The Last Decade

Claudio Pisano

164 papers receiving 5.9k citations

Peers

Countries citing papers authored by Claudio Pisano

Since Specialization

Citations

This map shows the geographic impact of Claudio Pisano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Pisano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Pisano more than expected).

Fields of papers citing papers by Claudio Pisano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Pisano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Pisano. The network helps show where Claudio Pisano may publish in the future.

Co-authors

The 25 scholars most cited alongside Claudio Pisano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Claudio Pisano Line = papers co-authored together Claudio Pisano links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Novel ST1926 Nanoparticle Drug Formulation Enhances Drug Therapeutic Efficiency in Colorectal Cancer Xenografted Mice Nanomaterials ·Sara Assi, Berthe Hayar, Claudio Pisano, Nadine Darwiche, Walid Saad	2024	1
2	Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma Journal of Experimental & Clinical Cancer Research ·Salih Demir, Alina Hotes, Tanja Schmid, Stefano Cairo, Émilie Indersie, Claudio Pisano, Eiso Hiyama, Tomoro Hishiki, Christian Vokuhl, Sophie Branchereau, Penelope Brock, Irene Schmid, József Zsíros, Roland Kappler	2024	5
3	Direct and indirect regulation of β-glucocerebrosidase by the transcription factors USF2 and ONECUT2 npj Parkinson s Disease ·Kathi Ging, Lukas Frick, Johannes C. M. Schlachetzki, Andrea Armani, Yanping Zhu, Pierre‐André Gilormini, Ashutosh Dhingra, Desirée Böck, Ana Marques, Matthew C. Deen, Xi Chen, Tetiana Serdiuk, Chiara Trevisan, Stefano Sellitto, Claudio Pisano, Christopher K. Glass, Peter Heutink, Jiang‐An Yin, David J. Vocadlo, Adriano Aguzzi	2024	0
4	Antitumor Effect of the Atypical Retinoid ST1926 in Acute Myeloid Leukemia and Nanoparticle Formulation Prolongs Lifespan and Reduces Tumor Burden of Xenograft Mice Molecular Cancer Therapeutics ·Leeanna El–Houjeiri, Walid Saad, Berthe Hayar, Patrick Aouad, Nadim Tawil, Rana Abdel‐Samad, Rita Hleihel, Maguy Hamie, Angelo Mancinelli, Claudio Pisano, Hiba El Hajj, Nadine Darwiche	2017	14
5	Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models Anti-Cancer Drugs ·Patrick Aouad, Melody Saikali, Rana Abdel‐Samad, Sabreen Fostok, Leeanna El–Houjeiri, Claudio Pisano, Rabih Talhouk, Nadine Darwiche	2017	27
6	Synergistic Antitumor Activity of Cetuximab and Namitecan in Human Squamous Cell Carcinoma Models Relies on Cooperative Inhibition of EGFR Expression and Depends on High EGFR Gene Copy Number Clinical Cancer Research ·Michelandrea De Cesare, Calogero Lauricella, Silvio Veronese, Denis Cominetti, Claudio Pisano, Franco Zunino, Nadia Zaffaroni, Valentina Zuco	2013	6
7	Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models Biochemical Pharmacology ·Giuliana Cassinelli, Cinzia Lanzi, Monica Tortoreto, Denis Cominetti, Giovanna Petrangolini, Enrica Favini, Nadia Zaffaroni, Claudio Pisano, Sergio Penco, Israël Vlodavsky, Franco Zunino	2013	72
8	Development and therapeutic impact of HDAC6-selective inhibitors Biochemical Pharmacology ·Sabrina Dallavalle, Claudio Pisano, Franco Zunino	2012	128
9	SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis Clinical Cancer Research ·Joseph P. Ritchie, Vishnu C. Ramani, Yongsheng Ren, Annamaria Naggi, Giangiacomo Torri, Benito Casu, Sergio Penco, Claudio Pisano, Paolo Carminati, Monica Tortoreto, Franco Zunino, Israël Vlodavsky, Ralph D. Sanderson, Yang Yang	2011	209
10	DNA Damage Persistence as Determinant of Tumor Sensitivity to the Combination of Topo I Inhibitors and Telomere-Targeting Agents Clinical Cancer Research ·Annamaria Biroccio, Manuela Porru, Angela Rizzo, Erica Salvati, Carmen D’Angelo, Augusto Orlandi, Daniela Passeri, Marco Franceschin, Malcolm F. G. Stevens, Éric Gilson, Giovanni Luca Beretta, Gabriella Zupi, Claudio Pisano, Franco Zunino, Carlo Leonetti	2011	29
11	Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice Diabetes ·Natali Gil, Rachel Goldberg, Tzahi Neuman, Marjolein Garsen, Eyal Zcharia, Ariel M. Rubinstein, Toin van Kuppevelt, Amichay Meirovitz, Claudio Pisano, Jin‐Ping Li, Johan van der Vlag, Israël Vlodavsky, Michael Elkin	2011	164
12	Role of Heparanase in Radiation-Enhanced Invasiveness of Pancreatic Carcinoma Cancer Research ·Amichay Meirovitz, Esther Hermano, Immanuel Lerner, Eyal Zcharia, Claudio Pisano, Tamar Peretz, Michael Elkin	2011	61
13	Neurophysiological and neuropathological evaluation of the bortezomib effect in myeloma-bearing mice Journal of the Peripheral Nervous System ·C Ceresa, C Meregalli, M Bossi, Claudio Pisano, Loredana Vesci, Rosanna Foderà, Guido Cavaletti	2011	1
14	Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl- l -Carnitine Clinical Cancer Research ·Claudio Pisano, Loredana Vesci, Ferdinando Maria Milazzo, Mario B. Guglielmi, Rosanna Foderà, Marcella Barbarino, Maurizio D’Incalci, Massimo Zucchetti, Giovanna Petrangolini, Monica Tortoreto, Paola Perego, Valentina Zuco, Augusto Orlandi, Daniela Passeri, Paolo Carminati, Claudio Cavazza, Franco Zunino	2010	24
15	A Placental Growth Factor Variant Unable to Recognize Vascular Endothelial Growth Factor (VEGF) Receptor-1 Inhibits VEGF-Dependent Tumor Angiogenesis via Heterodimerization Cancer Research ·Valeria Tarallo, Loredana Vesci, Onofrio Capasso, Maria Teresa Esposito, Teresa Riccioni, Lucio Pastore, Augusto Orlandi, Claudio Pisano, Sandro De Falco	2010	49
16	Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells Molecular Cancer Therapeutics ·Ralph Zinner, Brittany L. Barrett, Elmira Popova, Paul Damien, Andrei Y. Volgin, Juri G. Gelovani, Reuben Lotan, Hai T. Tran, Claudio Pisano, Gordon B. Mills, Mao Li, Waun Ki Hong, Scott M. Lippman, John H. Miller	2009	48
17	Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity Molecular Cancer Therapeutics ·Claudia Valli, Gabriela Paroni, Angela Maria Di Francesco, Riccardo Riccardi, Michele Tavecchio, Eugenio Erba, Andrea Boldetti, Maurizio Gianni’, Maddalena Fratelli, Claudio Pisano, Lucio Merlini, Antonio Antoccia, Chiara Cenciarelli, Mineko Terao, Enrico Garattini	2008	33
18	The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism Biochemical Pharmacology ·Angela Maria Di Francesco, Daniela Meco, Anna Rita Torella, Giuseppe Barone, Maurizio D’Incalci, Claudio Pisano, Paolo Carminati, Riccardo Riccardi	2006	24
19	Imatinib Mesylate Inhibits Leydig Cell Tumor Growth: Evidence for In vitro and In vivo Activity Cancer Research ·Sabrina Basciani, Marina Brama, Stefania Mariani, Gabriele De Luca, Mario Arizzi, Loredana Vesci, Claudio Pisano, Susanna Dolci, Giovanni Spera, Lucio Gnessi	2005	31
20	Acetyl-L-carnitine protects from peripheral neuropathy and reduces bone marrow injury in Taxol-treated mice Claudio Pisano, Loredana Vesci, Annalaura Bellucci, L Pacifici, Marilena Stasi, Cuono Cucco, B Camerini, M. Cervoni, S. Catanzaro, Barbara Bucci, D apos, Igea D' Agnano, Paolo Carminati	2000	1

About Claudio Pisano

Claudio Pisano is a scholar working on Toxicology, Oncology, Molecular Biology, Immunology and Allergy and Hematology, having authored 169 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (32 papers), Retinoids in leukemia and cellular processes (29 papers), Histone Deacetylase Inhibitors Research (17 papers), Proteoglycans and glycosaminoglycans research (15 papers), Peptidase Inhibition and Analysis (14 papers), Bioactive Compounds and Antitumor Agents (12 papers), Lung Cancer Research Studies (11 papers) and Synthesis and biological activity (11 papers). The work is most often cited by research in Toxicology (270 citations), Cell Biology (1.2k citations), Molecular Biology (4.0k citations), Immunology and Allergy (282 citations) and Oncology (1.3k citations). Claudio Pisano has collaborated with scholars based in Italy, Switzerland and Lebanon. Frequent co-authors include Franco Zunino, Loredana Vesci, Paolo Carminati, Giuseppe Giannini, Israël Vlodavsky, Sergio Penco, Sabrina Dallavalle, Silvia Bonaccorsi, Maurizio Gatti and Massimo Castorina. Their work appears in journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology, Cancer Research, Bioorganic & Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact